Dechra Pharmaceuticals PLC Director/PDMR Shareholding (9666F)
February 26 2018 - 10:50AM
UK Regulatory
TIDMDPH
RNS Number : 9666F
Dechra Pharmaceuticals PLC
26 February 2018
26 February 2018
Dechra(R) Pharmaceuticals PLC
(Dechra or the Company)
Notification and public disclosure of transactions by
persons discharging managerial responsibilities (PDMRs)
Dechra Pharmaceuticals PLC announces that on 26 February 2018,
Richard Cotton exercised a nil cost option over ordinary shares of
1p each in the Company. The option was granted to him on 7 March
2017 as part of the recruitment award referred to in the Company's
Directors' Remuneration Report for the year ended 30 June 2017.
The exercise of the option was subject to a performance review,
as result of which the vesting percentage is 100%.
Name Capacity Number of Total beneficial Percentage
share over shareholding of issued
which option following share
exercised this announcement capital
Richard
Cotton Director 21,033 42,351 0.041%
The Notification of Dealing Form set out below is provided in
accordance with the requirements of the EU Market Abuse
Regulation.
Notification of Dealing Form
1. Details of the Person Discharging Managerial
Responsibility ("PDMR")/person closely
associated with them ("PCA")
--- -----------------------------------------------------------------
a) Name Richard Cotton
--- ----------------------------- ----------------------------------
2. Reason for the notification
--- -----------------------------------------------------------------
a) Position/status Director/PDMR
--- ----------------------------- ----------------------------------
b) Initial notification/ Initial Notification
amendment
--- ----------------------------- ----------------------------------
3. Details of the Issuer
--- -----------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
--- ----------------------------- ----------------------------------
b) LEI code 213800J4UVB5OWG8VX82
--- ----------------------------- ----------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------------
a) Description Ordinary Shares of 1 pence
of the financial each
instrument
Identification ISIN: GB0009633180
code
--- ----------------------------- ----------------------------------
b) Nature of Exercise of an option granted
the transaction as part of a recruitment award
to acquire 21,033 shares
--- ----------------------------- ----------------------------------
c) Price(s) and Price(s) Volume(s)
volumes(s)
GBPNil Cost 21,033
--- ----------------------------- ------------------- -------------
d) Aggregated
information
* Aggregate volume N/A
* Price
--- ----------------------------- ----------------------------------
e) Date of the 2018.02.26
transaction
--- ----------------------------- ----------------------------------
f) Place of the Outside a trading venue
transaction
--- ----------------------------- ----------------------------------
For further information, please contact:
Melanie Hall, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is an international specialist veterinary pharmaceuticals
and related products business. Our expertise is in the development,
manufacture, and sales and marketing of high quality products
exclusively for veterinarians worldwide. Dechra's business is
unique as the majority of its products are used to treat medical
conditions for which there is no other effective solution or have a
clinical or dosing advantage over competitor products. For more
information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of
Dechra Pharmaceuticals PLC.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHFKADQPBKDFBB
(END) Dow Jones Newswires
February 26, 2018 10:50 ET (15:50 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2023 to Apr 2024